COMMUNIQUÉS West-GlobeNewswire

MyoKardia Presents Data from Study of Machine Learning Algorithm Intended to Identify Obstructive Hypertrophic Cardiomyopathy Using a Wearable Biosensor
14/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
Arbutus’ LNP Licensee Alnylam Receives Accelerated Assessment of Patisiran from European Medicines Agency (EMA)
13/11/2017
VANCOUVER, British Columbia and WARMINSTER, Pa., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, announced [...]
Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian Cancer
13/11/2017
Expert Advisory Board Endorses Randomized Phase I/II Trial in Newly Diagnosed Stage III and IV Ovarian Cancer GEN-1 Immunotherapy to Enter Phase I/II Clinical Study in the First Half of 2018 Following a Phase IB Trial [...]
Canada House Wellness Group provides Bi-Weekly Update on Status of Management Cease Trade Order
13/11/2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) wishes to [...]
OnePoint Patient Care and Hospice by the Bay Partner to Provide Dedicated Hospice Pharmacy Services in Northern California
13/11/2017
MORTON GROVE, Ill., Nov. 13, 2017 (GLOBE NEWSWIRE) -- OnePoint Patient Care, the leader in national hospice PBM and pharmacy services, announced its partnership with Hospice by the Bay, a leading not-for-profit hospice [...]
Royal Adelaide Hospital goes live with Allscripts EHR solution
13/11/2017
ADELAIDE, Australia, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) is in partnership with South Australia Health to deliver the Allscripts Sunrise™ product suite across the state of South Australia. The [...]
Clearside Biomedical, Inc. to Participate in Stifel 2017 Healthcare Conference
13/11/2017
ALPHARETTA, Ga., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, [...]
Royal Adelaide Hospital goes live with Allscripts EHR solution
13/11/2017
ADELAIDE, Australia, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) is in partnership with South Australia Health to deliver the Allscripts Sunrise™ product suite across the state of South Australia. The [...]
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Patients With Persistent High Triglycerides and Chronic Kidney Disease
13/11/2017
BEDMINSTER, N.J. and DUBLIN, Ireland, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Acura Pharmaceuticals Announces Third Quarter 2017 Financial Results
13/11/2017
PALATINE, Ill., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and nine [...]
Precipio, Inc. Announces Closing of $2,748,000 Registered Direct Offering
13/11/2017
NEW HAVEN, Conn., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), announced today that it has completed a registered direct offering for the purchase and sale of 2,748 units, each consisting of one [...]
Akcea Initiates AKCEA-ANGPTL3-LRx Phase 2 Program in Patients with Rare Hyperlipidemias
13/11/2017
CAMBRIDGE, Mass., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ), focused on developing and commercializing drugs to treat [...]
BeiGene Reports Third Quarter 2017 Financial Results
13/11/2017
CAMBRIDGE, Mass. and BEIJING, China, Nov. 13, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]
ImmuCell Announces Financial Results for Third Quarter of 2017
13/11/2017
PORTLAND, Maine, Nov. 13, 2017 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC ), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and [...]
OrthoPediatrics Corp. to Start Distributing Bioretec Devices via Private Label
13/11/2017
WARSAW, Ind., Nov. 13, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, and Bioretec Ltd. (“Bioretec”), [...]
Marrone Bio Innovations, Inc. Reports Third Quarter 2017 Financial Results
13/11/2017
DAVIS, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (“MBI” or the “Company”) (NASDAQ: MBII ), a leading provider of bio-based pest management and plant health products for the agriculture, [...]
TRACON Pharmaceuticals Announces Positive Results from Phase 1 Trial of TRC102 and Fludara® in Patients with Advanced Hematologic Malignancy Published in Oncotarget
13/11/2017
SAN DIEGO, Nov. 13, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
BeiGene Expands Global Pivotal Program for BTK Inhibitor BGB-3111
13/11/2017
Initiates global Phase 3 trial of BGB-3111 compared to bendamustine and rituximab (BR) in treatment-naïve chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL) patients Initiates global pivotal Phase 2 [...]
Spine Injury Solutions Reports Strong Q3 2017 Financial Results And Corporate Advances - Reminds For Conference Call 4:20 ET Today
13/11/2017
HOUSTON, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), a technology-driven, medical service, equipment and healthcare solution and financing company servicing the multi-billion dollar [...]

Pages